Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg)

Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg)
  Each film coated tablet contains:
  Voglibose IP………………………………………….0.3mg
  Repaglinide IP……………………………………….0.5mg
  Metformin Hydrochloride IP…………………………..500mg
  (In Sustained release form)
  Excipients……………………………………………..q.s
  Colour: Sunset Yellow FCF

THERAPEUTIC INDICATIONS:

Voglibose suppresses the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose, thereby delaying glucose absorption. Repaglinide increases the amount of insulin (glucose lowering hormone) released from the pancreas during meals. Together, they prevent blood sugar from rising very high after meals. Metformin works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body’s sensitivity to insulin.

CAUTION & SCHEDULE:

CAUTION:  Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed. 

CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG CAUTION: To be sold by retail on the prescription of a registered medical practitioner only. 

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg)

Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) represent a modern, scientifically balanced triple-combination oral antidiabetic therapy widely prescribed for patients with Type 2 Diabetes Mellitus (T2DM) who fail to achieve adequate glycemic control with single or dual therapy.

This formulation works through three complementary mechanisms. Voglibose delays intestinal carbohydrate absorption, minimizing postprandial glucose spikes. Repaglinide stimulates rapid, meal-related insulin secretion, while Metformin HCL suppresses hepatic glucose production and improves insulin sensitivity. Together, they provide comprehensive control over fasting and post-meal blood glucose levels.

The global prevalence of diabetes is rising rapidly across Asia, Africa, Latin America, and the Middle East. As a result, the demand for fixed-dose combination antidiabetic tablets like Voglibose + Repaglinide + Metformin HCL is increasing worldwide. Healthcare providers prefer such combinations due to improved patient compliance, reduced pill burden, and superior clinical outcomes.

As a trusted Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) Manufacturer in India, Taj Pharma fulfills this global demand with high-quality, cost-effective, and regulatory-compliant products.

 Assurance of Quality, Purity & Compliance

Taj Pharma is a well-known Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) manufacturer in India, offering assurance of international-quality standards, product safety, and consistent purity. Manufactured in WHO-GMP compliant facilities, these tablets are designed for effective long-term diabetes management.

This triple-drug therapy:

• Helps maintain stable blood glucose levels

• Reduces post-meal sugar fluctuations

• Improves insulin utilization

• Supports better metabolic control

The tablets are typically taken with meals and require careful clinical monitoring, especially when used with other antidiabetic medications, due to the potential risk of hypoglycemia, gastrointestinal effects such as gas and diarrhea, and individual tolerance variations. Patients are always advised to consult healthcare professionals before use.

Clinical Considerations & Safety Profile

Renal Monitoring & Elderly Patients

Taj Pharma is a well-established Manufacturer, Exporter, and Supplier of Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) from Vapi, Gujarat, India. Since Metformin is excreted through the kidneys, elderly patients—who often exhibit reduced renal function—should have their kidney parameters monitored regularly while using metformin-containing products.

Repaglinide & Renal Function

According to pharmacokinetic data, Repaglinide is not significantly affected by renal disorders. Only about eight percent of a dose is excreted via the kidneys; however, total plasma clearance may be reduced in patients with renal impairment, requiring cautious use.

Common Side Effects

Repaglinide may cause side effects in some patients. Inform your doctor if any of the following persist or worsen:

• Headache

• Nasal congestion

• Joint aches

• Back pain

• Constipation

• Diarrhea

Metformin & Kidney Safety

Metformin does not damage healthy kidneys and may even slow the progression of diabetic nephropathy. However, in patients with existing kidney disease, impaired clearance increases the rare but serious risk of lactic acidosis, making medical supervision essential.

Dietary Precautions

Patients are advised to limit grapefruit and grapefruit juice consumption during treatment with Repaglinide, as it may alter drug metabolism.

In-Depth Details for Importers, Exporters & Buyers

Regulatory Documentation Provided

Taj Pharma supports smooth product registration and importation by providing:

• WHO-GMP Certificate

• ISO 9001:2015 Certification

• Certificate of Pharmaceutical Product (COPP)

• Free Sale Certificate (FSC)

• Certificate of Analysis (COA)

• Stability Data

• CTD / ACTD Dossier

Custom Packaging & Labeling

To meet diverse international market requirements, Taj Pharma offers:

• Alu-Alu blister packaging

• PVC-Alu blister packs

• Strip and bulk packaging

• Customized carton design

• Multilingual labeling

• Private labeling and contract manufacturing

Shelf Life, Storage & Dosage Form

• Dosage Form: Tablet

• Strength: 0.3mg + 0.5mg + 500mg

• Shelf Life: 24–36 months

• Storage Conditions: Store below 25°C, protected from moisture and light

Export Certifications

• WHO-GMP

• EU-GMP (subject to requirement)

• COPP

• FSC

• CTD Dossier support for regulated markets

Target Countries & Export Markets

Taj Pharma exports Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) to:

• Africa

• Southeast Asia

• Middle East

• Latin America

• CIS & Central Asia

Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

State-of-the-Art Manufacturing

• Advanced WHO-GMP compliant manufacturing units

• Automated tablet compression and packaging lines

• Stringent in-process and finished-product quality testing

Affordable Pricing & Quality Assurance

• Competitive pricing for bulk and franchise partners

• High-quality APIs sourced from approved suppliers

• Robust quality management systems

Global Presence & Supply Chain Support

• PAN India distribution network

• Efficient global logistics and export handling

• Dedicated regulatory and export documentation team

Top 20 Countries Exporting

Nigeria | Kenya | Ghana | Tanzania | Uganda | Myanmar | Vietnam | Philippines | Yemen | Afghanistan | Iraq | Iran | Peru | Bolivia | Chile | Mexico | Dominican Republic | Nepal | Cambodia |Ethiopia

Technical Product Specification Table

Call to Action  

Searching for a reliable Voglibose + Repaglinide + Metformin HCL Tablets (0.3mg+0.5mg+500mg) Manufacturer Supplier in India?

Taj Pharma is your trusted partner for:

• Bulk supply

• International exports

• PCD Pharma Franchise opportunities

👉 Contact Taj Pharma today to receive quotations, dossiers, samples, and customized export solutions for your market.

Top 20 FAQs  

1. What is this medicine used for?
   Management of Type 2 Diabetes.

2. Who manufactures this tablet in India?
   Taj Pharma Ltd.

3. Is it WHO-GMP certified?
   Yes.

4. Should it be taken with meals?
   Yes.

5. Does it control postprandial glucose?
   Yes.

6. Is renal monitoring required?
   Recommended, especially for elderly patients.

7. Can it cause hypoglycemia?
   Rarely, particularly with other antidiabetics.

8. Is private labeling available?
   Yes.

9. Does Taj Pharma provide COPP?
   Yes.

10. Is bulk export possible?
    Yes.

11. Is it suitable for elderly patients?
    With medical supervision.

12. Where is Taj Pharma located?
    Vapi, Gujarat, India.

13. Is PCD Pharma Franchise available?
    Yes.

14. What is the shelf life?
    Up to 36 months.

15. Can grapefruit be consumed?
    Should be limited.

16. Is it prescription-only?
    As per country regulations.

17. Does Taj Pharma support CTD dossiers?
    Yes.

18. Does it improve insulin sensitivity?
    Yes, due to Metformin.

19. What packaging options are available?
    Blister, strip, and bulk packs.

20. How can buyers contact Taj Pharma?
    Through official business inquiry channels.